Business
CORRECTION – Visionary Holdings Inc. Releases Final Fiscal Year 2025 Annual Report and Audited Financial Statements; Form 20-F Filing Pending
TORONTO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- In a release issued under the headline "CORRECTION – Visionary Holdings Inc." on Tuesday, January 13th by Visionary Holdings Inc. (Nasdaq: GV), please be advised there was an error in the attached Form 20-F PDF. The corrected release with the corrected attachment follows: Visionary Holdings Inc. Releases Final Fiscal Year 2025 Annual Report and Audited Financial Statements; Form 20-F Filing Pending Highlighting Strategic Transformation and Early Commerc
About this update from Visionary Holdings Inc.
[{"type":"text","content":"TORONTO, Jan. 20, 2026 (GLOBE NEWSWIRE) -- In a release issued under the headline "CORRECTION – Visionary Holdings Inc." on Tuesday, January 13th by Visionary Holdings Inc. (Nasdaq: GV), please be advised there was an error in the attached Form 20-F PDF. The corrected release with the corrected attachment follows:","length":325,"tagName":"p"},{"type":"text","content":"Visionary Holdings Inc. Releases Final Fiscal Year 2025 Annual Report and Audited Financial Statements; Form 20-F Filing Pending ","length":128,"tagName":"p"},{"type":"text","content":"Highlighting Strategic Transformation and Early Commercial Progress in Emerging Health Businesses","length":97,"tagName":"p"},{"type":"text","content":"Visionary Holdings Inc. (Nasdaq: GV) (the “Company”) today announced the public release of its final annual report and audited financial statements for the fiscal year ended March 31, 2025. The Company has completed its audited financial statements and finalized its annual report; however, the Company’s Annual Report on Form 20-F has not yet been filed with the U.S. Securities and Exchange Commission (the “SEC”). During the reporting period, the Company continued to advance its transition from a traditional education- and real estate-focused business toward a diversified platform centered on health management, anti-aging and premium medical aesthetics, complemented by its AI-enabled education business. Emerging health-related businesses generated initial revenue contributions during the fiscal year, representing early progress in the Company’s strategic repositioning and providing potential new growth avenues over the medium to long term.","length":952,"tagName":"p"},{"type":"text","content":"A copy of the Company’s final annual report, including its audited financial statements, is included as an attachment to this press release for informational purposes only. This document does not constitute a filing with the SEC. The Company intends to file its Annual Report on Form 20-F with the SEC following completion of applicable regulatory and procedural requirements.","length":376,"tagName":"p"},{"type":"text","content":"Financial Highlights","length":20,"tagName":"p"},{"type":"text","content":"For fiscal year 2025, total revenue was USD 5.04 million, representing a year-over-year decrease of 46.2%, primarily attributable to the ...